2026 NPPES data Hematology & Oncology Physician NPI 1588877377 M.D.
Verify on CMS →

MEENAKSHI THIRUNAVU, M.D.

Hematology & Oncology Physician in KANSAS CITY, Kansas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
748
Medicare Part D claims · 156 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
67%
generic claims · 33% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
92.2614/100
▲ 9 pts above national avg 83.1 · [object Object]
What the federal data reveals: MEENAKSHI THIRUNAVU, M.D. is a Hematology & Oncology Physician ([object Object]) practicing in KANSAS CITY, Kansas with a Medicare Part D prescribing footprint of 748 claims across 156 beneficiaries — 33% brand-name prescribing . Their CMS MIPS Final Score of 92.2614/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities .

What stands out: MEENAKSHI THIRUNAVU, M.D. reported a CMS MIPS final score of 92.2614 out of 100, above the 83.1 national average, and filed 748 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

MEENAKSHI THIRUNAVU, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

MEENAKSHI THIRUNAVU, M.D. at a glance

High performer (top quartile)

NPI registry status

Active

Issued 05/08/2007

NPI 1588877377

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

748 12% vs specialty avg

2023 prescription claims

Specialty avg: 847

MIPS final score

92.2614/100 9.1614% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Kansas

How Hematology & Oncology Physician compares to other specialties among Kansas providers

Kansas providers

Hematology & Oncology Physician share within Kansas

1. Hematology & Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hematology & Oncology Physician share within Kansas

Medicare quality performance — MIPS

MEENAKSHI THIRUNAVU, M.D.'s 2023 MIPS final score plotted against the Hematology & Oncology Physician national average

High performer (top quartile)
MIPS Final Score
92.2614/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Hematology & Oncology Physician) — 92.2614/100 vs national avg 83.1

0%100%National avg83%92.3%
MIPS final score (Hematology & Oncology Physician) — 92.2614/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MEENAKSHI THIRUNAVU, M.D. is a Hematology & Oncology Physician provider practicing in KANSAS CITY, Kansas, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1588877377. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MEENAKSHI THIRUNAVU, M.D. appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding M.D. credentials at UNIVERSITY OF KANSAS MEDICAL CENTER, KANSAS CITY, KS, 66160, with a listed phone of (913) 588-6029. NPI 1588877377 was issued on 05/08/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what THIRUNAVU most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 748 prescription claims written by this provider, covering 156 Medicare beneficiaries and totaling roughly $1.8 million in drug spend, split 33% brand-name and 67% generic by claim count, with an opioid prescribing rate of 4.5%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 92.2614/100 for the 2023 performance year (Quality 73.8353), compared with the national average of 83.1.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

UNIVERSITY OF KANSAS MEDICAL CENTER
KANSAS CITY, KS 66160

Provider Details

NPI 1588877377
Specialty Hematology & Oncology Physician
Credentials M.D.
Gender Female
NPI Issued 05/08/2007

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

92.2614
Final Score
Avg: 83.1
73.8353
Quality
100
Promoting Interoperability

Reporting: Alternative Payment Model

Hospital and facility affiliations

Facilities where MEENAKSHI THIRUNAVU, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

THE EMORY CLINIC INC
ATLANTA, GA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Brand vs generic prescribing mix · Above average

MEENAKSHI THIRUNAVU, M.D. — brand share 33.0%
Specialty average (est.)

33% brand-name claims vs 67% generic, on 748 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

748
Total Claims
$1.8M
Total Drug Cost
156
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,283
Total Day Supply
35,382
Brand vs Generic
33% brand / 67% generic
Brand Drug Cost
$1.6M
Generic Drug Cost
$189K
Opioid Claims
34 (4.5% rate)
Antibiotic Claims
16

Patient Demographics

Average Patient Age
73.5 years
Avg HCC Risk Score
1.80
Gender Split
74% female / 26% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Anastrozole
78
Eliquis
Apixaban
75
Hydroxyurea
54
Xarelto
Rivaroxaban
51
Tamoxifen Citrate
44
Ibrance
Palbociclib
34
Letrozole
27
Imatinib Mesylate
25
Ondansetron Hcl
22
Prochlorperazine Maleate
21

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How MEENAKSHI THIRUNAVU, M.D. fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

MEENAKSHI THIRUNAVU, M.D.'s 748 claims are below the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in Kansas

Other clinicians with the same primary specialty enrolled in Kansas, drawn from the same CMS NPPES roster as THIRUNAVU.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MEENAKSHI THIRUNAVU, M.D.'s specialty?
MEENAKSHI THIRUNAVU, M.D. specializes in Hematology & Oncology Physician and practices in KANSAS CITY, Kansas. Credentials: M.D..
How much does MEENAKSHI THIRUNAVU, M.D. prescribe under Medicare Part D?
In 2023, MEENAKSHI THIRUNAVU, M.D. wrote 748 Medicare Part D claims totaling $1.8M in drug costs for 156 beneficiaries.
What is MEENAKSHI THIRUNAVU, M.D.'s Medicare quality score?
MEENAKSHI THIRUNAVU, M.D. has a CMS MIPS Final Score of 92.2614/100 (Quality: 73.8353). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MEENAKSHI THIRUNAVU, M.D. located?
MEENAKSHI THIRUNAVU, M.D. is located at UNIVERSITY OF KANSAS MEDICAL CENTER, KANSAS CITY, KS, 66160. Phone: (913) 588-6029.
What is MEENAKSHI THIRUNAVU, M.D.'s NPI number?
MEENAKSHI THIRUNAVU, M.D.'s National Provider Identifier (NPI) is 1588877377, issued on 05/08/2007.
Does MEENAKSHI THIRUNAVU, M.D. prescribe more brand-name or generic drugs?
MEENAKSHI THIRUNAVU, M.D.'s prescribing is 33% brand-name and 67% generic drugs by claim count, with $1.6M in brand drug costs.
Does MEENAKSHI THIRUNAVU, M.D. prescribe opioids?
Yes, MEENAKSHI THIRUNAVU, M.D. had 34 opioid claims in 2023 with an opioid prescribing rate of 4.5%.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does MEENAKSHI THIRUNAVU, M.D. prescribe most often?
Based on 2023 Medicare Part D data, MEENAKSHI THIRUNAVU, M.D.'s most frequently prescribed drugs include Anastrozole, Eliquis, Hydroxyurea. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MEENAKSHI THIRUNAVU, M.D. accept Medicare?
MEENAKSHI THIRUNAVU, M.D. appears in CMS Medicare data with 748 Part D claims and 156 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MEENAKSHI THIRUNAVU, M.D.'s credentials?
MEENAKSHI THIRUNAVU, M.D.'s NPI is 1588877377 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology